This article is more than 5 years old. Information may no longer be current.

VIDEO: Speaker updates HORV task force findings on vancomycin

Issue: February 25, 2017

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

KOLOA, Hawaii ― At Hawaiian Eye 2017, David F. Chang, MD, discusses current knowledge of hemorrhagic occlusive retinal vasculitis as found by the HORV task force, which is comprised of members of the American Society of Cataract and Refractive Surgery and the American Society of Retina Specialists.

To date, the task force has collected data on HORV in 36 eyes of 23 patients. Because no true cases of HORV have been found in patients who did not receive vancomycin intraoperatively, it appears HORV is in some way a reaction to vancomycin, Chang said.